Home / AARTIDRUGS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AARTIDRUGS.NS make money? Does AARTIDRUGS.NS have pricing power? What's the Earnings Whisper? Will AARTIDRUGS.NS profit more as the business scales? What is AARTIDRUGS.NS's management track record? Is AARTIDRUGS.NS's current price justified?

Aarti Drugs Limited

₹396.35 -$20.30 (-4.87%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹396.45

Day Range

₹392.5₹399.45

Year Range

₹318.95₹534

Market Cap

36.17B

AVG Volume

193.91K

Trailing/Forward PE

18.93/14.21

PEG ratio

1.02

Dividend Yield

0.50%

Next Earnings Date

2026-10-22

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

AARTIDRUGS.NS Revenue (INR) by year
Period	Revenue (INR)
2026	25.65B
2025	23.87B
2024	25.29B
2023	27.16B
2022	24.89B
2021	21.55B
2020	18.06B
2019	15.61B
2018	12.44B
2017	11.95B

Net Income (INR) · A

AARTIDRUGS.NS Net Income (INR) by year
Period	Net Income (INR)
2026	1.95B
2025	1.68B
2024	1.71B
2023	1.66B
2022	2.05B
2021	2.8B
2020	1.41B
2019	897.51M
2018	823M
2017	805.9M

Operating Income (INR) · A

AARTIDRUGS.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	2.42B
2025	3.61B
2024	2.66B
2023	2.57B
2022	2.87B
2021	3.95B
2020	2.23B
2019	1.71B
2018	1.33B
2017	4.14B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aarti Drugs Limited

Video analysis: AARTIDRUGS.NS

News: AARTIDRUGS.NS

Similar companies